Table 3.
Baseline correlations among study variables.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. IES | - | ||||||||||||||
| 2. Intrusion | .89** | - | |||||||||||||
| 3. Avoidance | .88** | .57** | - | ||||||||||||
| 4. Depression | .60** | .65** | .41** | - | |||||||||||
| 5. TNF | .04 | .01 | .05 | .01 | - | ||||||||||
| 6. IL-6 | .02 | .01 | .03 | .08 | .60** | - | |||||||||
| 7. IL-1b | .11 | .15 | .05 | .21* | .29** | .15 | - | ||||||||
| 8. IL-8 | −.01 | −.07 | .05 | −.02 | .67** | .40** | .33** | - | |||||||
| 9. Composite | .04 | .04 | .03 | .09 | .79** | .72** | .66** | .45** | - | ||||||
| 10. Age | −.26** | −.30** | −.15* | −.30** | .14** | −.03 | −.03 | .07 | .06 | - | |||||
| 11. Comorbidities | .00 | .03 | −.02 | .01 | .03 | .04 | .08 | .01 | .06 | .19** | - | ||||
| 12. BMI | .12 | .08 | .13 | .14* | .10 | .17* | −.05 | −.04 | .12 | .02 | .04 | - | |||
| 13. Menopause | −.05 | −.09 | .01 | −.09 | .16* | .02 | .10 | .18* | .14* | .68** | .13 | .12 | - | ||
| 14. Cancer Tx | .05 | .10 | −.02 | .12 | −.11 | −.03 | .03 | −.19** | −.06 | −.15* | .02 | .08 | −.12 | - | |
| 15. Stage | .03 | .01 | .04 | .02 | −.01 | −.03 | −.09 | −.05 | −.06 | −.02 | .00 | .20** | .01 | .45** | - |
Note.
*
p < .05
**
p < .001
IES = Impact of Events Scale, IL-6 = interleukin 6, TNF-α = tumor necrosis factor alpha, IL-8 = interleukin 8, IL-1β = interleukin 1-beta, BMI = body mass index, Cancer Tx = cancer treatment type, Stage = cancer stage. Depression was measured using the Center for Epidemiological Studies- Depression scale.